Mirae Asset Global Etfs Holdings Ltd. Protalix Bio Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 34,167 shares of PLX stock, worth $42,025. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,167Holding current value
$42,025% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PLX
# of Institutions
63Shares Held
5.83MCall Options Held
103KPut Options Held
4.6K-
Israel Englander Millennium Management LLC | New York, Ny811KShares$997,7260.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny805KShares$989,6580.0% of portfolio
-
Goldman Sachs Group Inc New York, NY462KShares$568,2080.0% of portfolio
-
Gsa Capital Partners LLP London, X0435KShares$535,3110.03% of portfolio
-
Northern Trust Corp Chicago, IL423KShares$520,5510.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $61.2M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...